The Central Bureau of Investigation (CBI) probing the disproportionate assets case against Kadapa MP Y.S. Jaganmohan Reddy and others on Tuesday filed a supplementary charge-sheet in the case charging three pharmaceutical companies that they had resorted to violation of the Companies Act in investing in Jagan’s companies.

Submitting the supplementary documents of charges to a special court, Deputy Legal Advisor to CBI B. Ravindranath said that the investigating agency had specific information from the Registrar of Companies here on the violation of the Companies Act by three pharmaceutical companies named accused in the first charge-sheet filed in the case.

Voluminous report

The RoC had given its report recently and the same was submitted as the supplementary charge-sheet. It contained 29 pages and eight documents after examining nine persons, mostly officials of the RoC, as witnesses. Neither there were additions to the list of 13 accused in the first charge-sheet nor fresh sections were added against them, he told the court.

When the judge asked about the status of investigation in seven pending aspects and about CBI’s undertaking given to the Supreme Court, the CBI counsel said probe into three aspects was completed and it was in progress in the remaining four.

The agency had not given any written undertaking to the apex court but it had stated orally that the probe would be completed as early as possible.

More charge-sheets

He further submitted that the CBI would file two or more charge-sheets in the pending aspects with short span in between.

The CBI also urged the court to take cognisance of charges under Section 9 of the Prevention of Corruption Act against Jagan.

In the charge-sheet filed on March 31 last year, the CBI alleged that Aurobindo Pharma, Hetero Drugs and Trident Life Sciences had invested Rs. 36.5 crore in Jagati Publications and in turn got lands allotted with the influence of Jagan at a much lesser price than then the prevailing land rates.